Donato laboratorija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 125,696 | 174,367 | 183,631 | 238,387 | 244,204 | 290,744 | 327,574 | 338,105 |
| Profit before tax | - | - | - | - | - | - | - | 32,904 |
| Net profit | 36,902 | 38,948 | 49,242 | 42,730 | -413 | 68,004 | 32,129 | 27,302 |
| Equity | 55,590 | 78,118 | 103,246 | 143,105 | 130,713 | 198,717 | 216,846 | 84,395 |
| Liabilities | 4,171 | 5,562 | 23,599 | 53,347 | 42,948 | 235,319 | 195,855 | 59,784 |
| Non-current assets | 16,831 | 6,518 | 61,701 | 120,756 | 106,714 | 295,281 | 301,918 | 22,149 |
| Current assets | 42,930 | 77,162 | 65,144 | 75,696 | 56,417 | 133,087 | 110,159 | 122,030 |
| Total assets | 59,761 | 83,680 | 126,845 | 196,452 | 163,131 | 428,368 | 412,077 | 144,179 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 26,156 | 57,025 | 63,707 |
| Social insurance contributions | - | - | - | - | - | 16,347 | 30,296 | 8,684 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +58.3% | +38.7% | +5.3% | +29.8% | +2.4% | +19.1% | +12.7% | +3.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 61.7% | 46.5% | 38.8% | 21.8% | -0.3% | 15.9% | 7.8% | 18.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 66.4% | 49.9% | 47.7% | 29.9% | -0.3% | 34.2% | 14.8% | 32.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 29.4% | 22.3% | 26.8% | 17.9% | -0.2% | 23.4% | 9.8% | 8.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | 9.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 1.2 | 0.9 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,424 | 36,709 | 50,081 | 59,597 | 61,051 | 85,095 | 81,894 | 115,920 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Donato laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-07-24 | 2025-08-18 | 0.84 |
| 2025-05-04 | 2025-05-14 | 0.13 |
| 2025-04-24 | 2025-04-29 | 0.13 |
| 2025-04-16 | 2025-04-16 | 3109.04 |
| 2025-03-18 | 2025-03-20 | 118.53 |
| 2025-02-18 | 2025-03-13 | 0.46 |
| 2025-01-22 | 2025-02-16 | 0.45 |
| 2024-11-18 | 2024-11-20 | 279.21 |
| 2024-10-24 | 2024-11-11 | 0.90 |
| 2023-08-17 | 2023-08-20 | 2583.14 |
| 2023-07-18 | 2023-08-16 | 0.08 |
| 2023-06-16 | 2023-07-11 | 0.07 |
| 2023-05-25 | 2023-06-11 | 0.07 |
| 2023-03-16 | 2023-03-26 | 3.89 |
| 2022-06-16 | 2022-07-12 | 1.30 |
| 2022-05-17 | 2022-06-14 | 1.30 |
| 2022-04-19 | 2022-05-10 | 1.31 |
| 2022-03-16 | 2022-04-14 | 1.31 |
| 2022-02-17 | 2022-03-14 | 1.31 |
| 2022-01-28 | 2022-02-14 | 1.31 |
| 2022-01-18 | 2022-01-27 | 0.65 |
| 2021-12-16 | 2022-01-10 | 0.66 |
| 2021-11-16 | 2021-12-13 | 0.66 |
| 2021-11-05 | 2021-11-15 | 1.26 |
| 2021-10-18 | 2021-11-04 | 0.60 |
| 2021-09-16 | 2021-10-11 | 0.60 |
Donato laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 945.25 |
| 2025-11-02 | 2025-12-11 | 0.23 |
| 2025-10-02 | 2025-11-01 | 0.39 |
| 2025-08-19 | 2025-09-17 | 2.8 |
| 2025-08-15 | 2025-08-18 | 168.02 |
| 2025-08-12 | 2025-08-14 | 21353.54 |
| 2025-07-31 | 2025-08-11 | 2.84 |
| 2025-06-25 | 2025-07-30 | 3.48 |
| 2025-06-21 | 2025-06-24 | 2.61 |
| 2025-06-20 | 2025-06-20 | 3227.61 |
| 2025-06-19 | 2025-06-19 | 3225.87 |
| 2025-05-17 | 2025-05-20 | 25.38 |
| 2025-05-11 | 2025-05-16 | 3105.82 |
| 2025-05-05 | 2025-05-10 | 2897.32 |
| 2025-05-01 | 2025-05-04 | 2894.24 |
| 2025-04-24 | 2025-04-30 | 2888.08 |
| 2025-04-23 | 2025-04-23 | 2888.12 |
| 2025-04-16 | 2025-04-22 | 2860.4 |
| 2025-04-03 | 2025-04-12 | 3.32 |
| 2025-03-15 | 2025-04-02 | 0.48 |
| 2025-03-08 | 2025-03-14 | 3.32 |
| 2025-02-20 | 2025-03-07 | 0.48 |
| 2025-02-18 | 2025-02-18 | 34.79 |
| 2025-01-31 | 2025-02-17 | 37.63 |
| 2025-01-25 | 2025-01-30 | 952.5 |
| 2024-10-10 | 2024-10-16 | 25.2 |
| 2024-10-04 | 2024-10-09 | 2776.77 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Donato laboratorija, MB (code 302764099) is a small partnership engaged in other human health activities n.e.c. In 2025, the company generated revenue of €338.1K, up 3.2% year on year and 16.3% over two years. Net profit was €27.3K, with a profit margin of 8.1%, indicating that profitability has remained positive but has eased from earlier years. In 2023, revenue was €290.7K and net profit €68.0K, while in 2024 revenue increased to €327.6K and profit declined to €32.1K. The latest figures show continued top-line growth alongside a lower earnings level. The 2025 balance sheet shows total assets of €144.2K, equity of €84.4K and liabilities of €59.8K. Long-term assets were €22.1K and short-term assets €122.0K. Key ratios indicate an equity ratio of 58.5%, debt-to-equity of 0.71, asset turnover of 2.35x, ROE of 32.4% and ROA of 18.9%. Revenue per employee was €169.1K and profit per employee €13.7K, reflecting solid operating productivity in 2025.